Home > Financial Ratios > BAFNA PHARMACEUTICALS

BAFNA PHARMACEUTICALS
EV/Core EBITDA

    Back to All Ratios
COMMUNITY POLL
for BAFNA PHARMACEUTICALS
Please provide your vote to see the results

BAFNA PHARMACEUTICALS Last 5 Year EV/Core EBITDA History

[Standalone]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EV/Core EBITDA(x) 13.9611.0922.7930.42-2.27

What is the latest EV/Core EBITDA ratio of BAFNA PHARMACEUTICALS ?

The latest EV/Core EBITDA ratio of BAFNA PHARMACEUTICALS is 13.96 based on Mar2024 Standalone results.
Year EV/Core EBITDA
Mar202413.96
Mar202311.09
Mar202222.79
Mar202130.42
Mar2020-2.27

How is EV/Core EBITDA of BAFNA PHARMACEUTICALS Trending?

Years EV/Core EBITDA % Change
Mar2024 13.96
25.88
Mar2023 11.09
-51.34
Mar2022 22.79
-25.08
Mar2021 30.42
Positive
Mar2020 -2.27 -

Other Financial Ratios of BAFNA PHARMACEUTICALS


Compare EV/Core EBITDA ratio of peers of BAFNA PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS ₹191.8 Cr -2.9% NA -0.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹383,570.0 Cr -6.5% -4.7% -5.1% Stock Analytics
DIVIS LABORATORIES ₹162,808.0 Cr -7.1% -11.5% 32.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹121,734.0 Cr -5.8% 6.1% 13.3% Stock Analytics
CIPLA ₹120,468.0 Cr -4.3% -0.1% -1% Stock Analytics
DR REDDYS LABORATORIES ₹100,212.0 Cr -5.8% -6.8% -11% Stock Analytics


BAFNA PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS

-2.9%

NA

-0.2%

SENSEX

-0.7%

-3.7%

2.4%


You may also like the below Video Courses